Cardiac metastasis from a Pancoast tumour presenting with ST-segment elevation and 2:1 atrioventricular block: a case report Authors: Qing Yi Fang, Vincenzo Somma, Paul B Sparks, Felix Wiedmann, Guglielmo Fibbi, Deepti Ranganathan Published: 2026 ABSTRACT AbstractBackgroundCardiac metastases are significantly more common than primary cardiac tumours. Their clinical presentation varies depending on tumour size, location, and degree of myocardial or pericardial infiltration. Common manifestations include pericardial effusion, valvular dysfunction due to inflow or outflow obstruction, and conduction disturbances. 2:1 atrioventricular (AV) block secondary to cardiac metastases is rare.Case SummaryWe report a case of a 69-year-old man with a Pancoast tumour who presented with hyperacute ST-segment elevation and 2:1 AV block. Transthoracic echocardiography (TTE) and positron emission tomography (PET) revealed intracardiac metastases. A permanent dual-chamber pacemaker was implanted for symptomatic 2:1 AV block. The patient died from advanced malignancy shortly after device implantation.DiscussionThis case highlights 2:1 AV block as an uncommon manifestation of cardiac metastases. Multimodality imaging, particularly TTE, cardiac magnetic resonance imaging, and cardiac PET, plays a pivotal role in timely diagnosis. Permanent pacemaker implantation in such cases is a challenge in terms of clinical utility and palliative care. Decisions regarding permanent pacing should be shared between the patient and clinicians, incorporating balance between clinical indications, patient’s comorbidities, prognosis, and preferences.Keywords: Cardiac metastasis, Pancoast tumour, Atrioventricular block, ST-segment elevation, Case report Cardiac tumours are a rare cause for unexplained ST-segment elevation and conduction disease. Cardiac tumours are a rare cause for unexplained ST-segment elevation and conduction disease. Diagnosis of cardiac metastases requires a multimodality imaging approach including the use of ECG, echocardiography, cardiac MRI, and PET. Diagnosis of cardiac metastases requires a multimodality imaging approach including the use of ECG, echocardiography, cardiac MRI, and PET. Introduction Cardiac metastases are much more common than primary cardiac tumours, with a reported prevalence ranging from 2.3% to 18.3%, most often secondary to primary lung cancer.1 Pancoast tumours are aggressive neoplasms originating from the superior primary sulcus and account for fewer than 5% of lung cancer.2 Classically, they present with shoulder and arm pain, Horner’s syndrome, and atrophy of the intrinsic hand muscles.2 The clinical manifestations of cardiac metastases depend on tumour location, size, and extent of invasion. We describe a rare case of cardiac metastasis from a Pancoast tumour presenting as hyperacute ST-segment elevation and 2:1 atrioventricular (AV) block. Summary figure Case presentation A 69-year-old man with a significant smoking history presented to the emergency department with progressive right shoulder pain, right-hand weakness, and presyncope. He was of normal body habitus, with no prior electrocardiographic abnormalities or known cardiac disease. Past medical history was positive for chronic obstructive pulmonary disease and hypertension. On examination, he was bradycardic, with a heart rate of 48 beats/min. The 12-lead electrocardiogram (Figure 1) demonstrated new 2:1 AV block with coved ST-segment elevation in the anteroinferior leads, raising concern for an extensive acute myocardial infarction. Laboratory diagnostics revealed neutrophilic leucocytosis with white blood cell count of 13.8 × 109 (normal range: 4.0–12.0 × 109/L) and neutrophil count of 10.6 × 109 (normal range: 2.0–8.0 × 109/L), elevated C-reactive protein at 35 mg/L (normal range <5.0 mg/L), hypokalaemia of 3.4 mmol/L (normal range 3.5–5.2 mmol/L), and hypercalcaemia of 2.80 mmol/L (normal range: 2.10–2.60 mmol/L). Initial troponin levels were elevated at 260 ng/L and subsequently peaked at 732 ng/L (normal range <14 ng/L). Urgent coronary angiography was therefore performed; however, no culprit lesion was identified. A temporary pacing system was inserted at the time. ECG demonstrating 2:1 atrioventricular block with coved ST-segment elevation in the anteroinferior leads. Subsequent computed tomography (CT) demonstrated a large cavitating lesion in the superior sulcus (Figure 2), in keeping with a Pancoast tumour with evidence of cardiac involvement (Figure 3). A diagnosis of a Pancoast tumour primary with nodal metastases was confirmed on tissue biopsy. Lung-windowed CT chest. (A) Axial and (B) coronal views demonstrating a large 62 × 55 mm necrotic mass with central cavitation, primarily centred within the right apical segment. Soft tissue axial chest demonstrating multiple soft tissue density lesions within the cardiac myocardium, involving the left ventricle and interventricular septum, the largest measuring approximately 62 × 42 mm in the axial plane (arrow). Appearances are consistent with cardiac metastases. Bilateral malignant pleural effusions are also noted (arrowhead). Transthoracic echocardiography (TTE) revealed a large, heterogeneous mass involving the left ventricular apex, interventricular septum, and inferior and inferolateral walls, thus corroborating cardiac involvement. 18F-fluorodeoxyglucose positron emission tomography—CT (18F-FDG PET-CT) demonstrated intense PET avidity within the anterior wall and septum (Figure 4), confirming myocardial metastases. Anterior wall involvement likely underpinned both the ST-segment elevation and the infra-Hisian conduction abnormality. 18F-FDG PET-CT. (A) Axial and (B) coronal views of the chest demonstrating high 18F-FDG uptake in the right upper lobe apical lung mass with extension to the myocardium and pericardium, consistent with cardiac metastases. The 2:1 AV block persisted despite correction of electrolyte abnormalities and was associated with haemodynamic instability and ongoing pacing dependence. Therefore, a decision was made to implant a dual-chamber pacemaker following multidisciplinary discussion between cardiology and oncology teams. Over the ensuing months, the patient progressively deteriorated with increasing debility, anorexia, weight loss, and worsening respiratory symptoms. Repeat imaging demonstrated rapid progression of disease, complicated by pulmonary infection and sarcopenia. In view of his poor performance status and advanced disease, the patient was transitioned to palliative care and died shortly after. Discussion The heart is an uncommon site of metastatic disease. Lung cancer represents the most common primary tumour metastasizing to the heart, owing to both its prevalence and anatomical proximity.1 Pancoast tumours, account for 3%–5% of lung cancers, arise at the lung apex and often invade nearby structures at the chest wall and thoracic inlet.2 To our knowledge, this represents the first reported case of a Pancoast tumour presenting with hyperacute ST-segment elevation and 2:1 AV block secondary to cardiac metastasis. The diagnostic process of cardiac metastases remains challenging due to the subtlety of their presentation and the absence of a standardized diagnostic pathway. Symptoms are often non-specific and can mimic primary cardiac diseases. Multimodality imaging approach is crucial in the early identification of cardiac involvement. TTE is the initial imaging of choice for differentiating benign from malignant cardiac masses. Malignant lesions typically appear larger, irregular, inhomogeneous, sessile, and multilobulated.3 Functionally, malignant masses reduce cardiac output and cause intra-cavity obstruction or valvular dysfunction.3 However, poor acoustic windows, operator dependence, and artefacts often limit TTE in sufficiently defining cardiac metastases. CT, transoesophageal echocardiography (TEE), cardiac magnetic resonance (CMR), and positron emission tomography (PET) provide additional incremental information on tissue characterization, extent of infiltration, and disease activity. TEE is particularly useful for further characterization of morphology, haemodynamics, and function of an intracardiac mass.4 It is also advantageous for assessing right heart structures, including the vena cavae, right ventricular outflow tract, pulmonic valve, and pulmonary trunk, owing to the absence of thoracic interference, higher frequency ultrasound, and improved visualization of posterior structures.5 In this case, TEE was not pursued as no right-sided cardiac lesions were identified on TTE. CMR offers superior tissue characterization, with most cardiac metastases appearing hypointense on T1-weighted and hyperintense on T2-weighted images, with prominent late-gadolinium enhancement.6 However, CMR was not performed in this patient due to the presence of a recently implanted pacemaker, which limited feasibility in the acute setting. PET provides accurate metabolic and prognostic assessment. Malignant masses typically exhibit high 18F-FDG uptake, with higher maximum standardized uptake value (SUVmax) correlating with poorer prognosis.7 The clinical manifestations of metastatic cardiac tumours vary widely and may include arrhythmias, embolic events, or acute coronary syndrome-like presentations.8 ECG abnormalities commonly reported include ST-T wave changes, atrial fibrillation or flutter, bundle branch block, and other non-specific conduction disturbances.9 Several mechanisms have been proposed to explain ECG abnormalities observed in cardiac metastases, including coronary artery compression or invasion, pericardial involvement, and direct myocardial infiltration.8 In this case, ST-segment elevation in inferior (II, III, aVF) and anterior precordial (V2-V6) leads corresponded to the site of metastatic involvement identified on imaging. Infra-Hisian conduction block is an uncommon manifestation of cardiac metastasis and has been previously reported in association with anaplastic, bronchogenic, and squamous cell carcinomas.10 At present, there are no evidence-based guidelines for managing 2:1 AV block in the context of advanced malignancy. The decision to implant a permanent pacemaker should be individualized, balancing symptom relief, quality of life, and overall prognosis.11 In our case, it was thought that 2:1 AV block might be reversible on resolution of electrolyte imbalance. However, the persistence of 2:1 AV block causing haemodynamic instability despite correction of potential reversible causes necessitated the implantation of a dual-chamber pacemaker. This incidentally also rendered the patient suitable for life-prolonging radiotherapy, thereby maximizing therapeutic benefit despite non-curative intent. This case highlights the diverse cardiac manifestations of metastatic Pancoast tumours and emphasizes the critical role of multimodality imaging in establishing diagnosis. Early recognition facilitates tailored management and informed goals-of-care discussions in patients with advanced cancer. Acknowledgements None. Contributor Information Qing Yi Fang, Department of Cardiology, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia. Vincenzo Somma, Department of Cardiology, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia. Paul B Sparks, Department of Cardiology, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia. Lead author biography For image description, please refer to the figure legend and surrounding text. Qing Yi currently works at The Royal Melbourne Hospital and has a keen interest in Cardiology. Author contributions Qing Yi Fang (Writing—original draft, Writing—review & editing [lead]), Vincenzo Somma (Supervision [supporting], Writing—review & editing [equal]), and Paul B. Sparks (Conceptualization, Supervision [lead], Writing—review & editing [supporting]) Consent The authors confirm that written consent for submission and publication of this case report has been obtained from the patient in line with the Committee on Publication Ethics guidance. Funding None. Data availability All data underlying the results are available as part of the article and no additional source data are required. References Associated Data Data Availability Statement All data underlying the results are available as part of the article and no additional source data are required.